Discontinuing GLP-1 RAs before or during early pregnancy is linked to increased gestational weight gain and pregnancy complications. GLP-1 RAs are not recommended during pregnancy due to potential ...

In a study led by researchers at Mass General Brigham, pregnant individuals who stopped taking popular weight loss GLP-1 medications before or early in their pregnancy tended to gain more weight and ...

New research shows that women who halt GLP-1 medications near conception face greater gestational weight gain and elevated risks for preterm birth and pregnancy-related complications, raising urgent ...

GLP-1 receptor agonists are contraindicated in pregnancy. In a cohort of women primarily with obesity, GLP-1 receptor agonist exposure prior to pregnancy or in early pregnancy was associated with ...

Compared with unexposed pregnancies, the GLP-1 RA group had a higher risk for excess gestational weight gain, and a higher risk for preterm delivery, gestational diabetes, and hypertensive disorders ...

About The Study: In a cohort composed primarily of women with obesity, glucagon-like peptide-1 receptor agonist (GLP-1RA) use with subsequent pre-pregnancy or early pregnancy discontinuation was ...

This virtual workshop examined issues related to obesity before, during, and after pregnancy. The webinar featured individual invited speakers and presentations that build on previous topics covered ...

Around two-thirds (68%) of pregnancies have weight gain that is more or less than recommended and that is associated with complications such as preterm birth, large birth weight, and admission to ...

Plus-size pregnancies can carry extra risks – but with good care and support, you can have a healthy pregnancy and baby. Here's how.

Share on Pinterest New research suggests that stopping GLP-1 drugs before pregnancy is linked to complications like gestational diabetes and preeclampsia. Tatsiana Volkava/Getty Images A recent study ...